NewAmsterdam Pharma Company N.V.
NAMSNASDAQ
USReal-Time Price
USReal-Time Price$21.50USD
+1.03 (+5.03%)Today
$21.45-0.05 (-0.23%)After Hours6:39 PM ET
BTI Score
Near Future
37
Long Term
38
BTI Fair Market Cap
$729.29M
+252.40% vs fair
High Risk
NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NewAmsterdam Pharma Company N.V. (NAMS) earnings: next report date, EPS and revenue consensus, historical surprises and the full quarterly results timeline.
Earnings Trends
Earnings Per Share
Revenue Beat Rate
78%
Beat
7Meet
0Miss
2Total
9EPS Beat Rate
0%
Beat
0Meet
0Miss
0Total
0Earnings Consistency
0%
Both Beat
0Other
0Total
0Quarterly EPS Performance
Recent results and upcoming quarter
Q2 FY26
30 / 06 / 2026
Estimate—
Actual—
Surprise—
Q1 FY26
31 / 03 / 2026
Estimate—
Actual—
Surprise—
Q4 FY25
31 / 12 / 2025
Estimate—
Actual—
Surprise—
Q4 FY26
04 / 11 / 2026
Estimate$-0.49
Actual—
Surprise—
Revenue vs Earnings Over Time
Revenue (B USD)
Net Income (B USD)
Profit Margin (%)
EPS: Estimate vs Reported
Earnings History
| Quarter | EPS Est. | Reported EPS | Surprise | Rev. Est. | Reported Rev. | Date |
|---|---|---|---|---|---|---|
| Q2 FY26 | — | — | —▼ Miss | $2.83M | $3.70M | 30 / 06 / 2026 |
| Q1 FY26 | — | — | —▼ Miss | $1.75M | $3.04M | 31 / 03 / 2026 |
| Q4 FY25 | — | — | —▼ Miss | $0.00 | $3.04M | 31 / 12 / 2025 |
| Q3 FY25 | — | — | —▼ Miss | $4.54M | $348000.00 | 30 / 09 / 2025 |
| Q2 FY25 | — | — | —▼ Miss | $1.44M | $19.15M | 30 / 06 / 2025 |
| Q1 FY25 | — | — | —▼ Miss | $1.46M | $2.98M | 31 / 03 / 2025 |
| Q4 FY24 | — | — | —▼ Miss | $3.30M | $12.77M | 31 / 12 / 2024 |
| Q2 FY24 | — | — | —▼ Miss | $2.20M | $2.28M | 30 / 06 / 2024 |
| Q1 FY24 | — | — | —▼ Miss | $2.95M | $1.40M | 31 / 03 / 2024 |
Source: FMP Earnings Calendar API. Surprise = (Actual − Estimate) / |Estimate| × 100.
NAMS upcoming earnings call
04 / 11 / 2026
ScheduledEPS Est: $-0.49